ArticleBMC cancer2023

Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer.

Yohei Harada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.